Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.
about
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.Implications of heterogeneity in multiple myeloma.How we manage autologous stem cell transplantation for patients with multiple myelomaMapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesA novel measure of chromosome instability can account for prognostic difference in multiple myeloma.MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human DiseasesDNA damage induced MutS homologue hMSH4 acetylation.Genomic stratification of multiple myeloma treated with novel agents.IMWG consensus on risk stratification in multiple myeloma.Cytogenetic Alterations in Multiple Myeloma: Prognostic Significance and the Choice of Frontline Therapy.Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.Copy number variations could predict the outcome of bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.Long Non-Coding RNAs in Multiple Myeloma.New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
P2860
Q30275382-84BD08B1-0393-4DB5-A7AB-CE0A81B19195Q33914824-B7804457-4507-4435-8E9D-E9D8DAD77884Q34019581-D1C33352-788A-4A1E-B78E-63E1BA32BAD0Q34223730-19A04A37-F934-49E1-B9D8-98A92F94456CQ34272540-EA81C1BF-A545-4FA0-A52F-D24C6B13001BQ34805291-9779F7F5-CCA3-460C-8ADA-1773ABD5DB2EQ36798895-BB3774AE-5E96-4C6D-B748-26E8E69EF981Q37291391-FDC0D162-9DFB-4CC4-9AE6-598176B21108Q37913346-1D9B7EF9-23BD-4BF1-96ED-5AE8607BF2D7Q38131380-85F05BC7-5106-4A2C-9F7E-8AA7D8D7E444Q38617375-1698905F-73C6-408A-9F55-B274F48B6473Q39518931-25F735FF-A6E0-4581-A69E-59F587C422A9Q39788992-9299B220-CD1A-476B-9B17-58E63883CC06Q42181641-BEFCA2D1-BE7F-4DAB-8486-50EA51FF745DQ42867447-C7A71262-42F9-4F41-830D-79BA337BA6FBQ45219012-B9BF96C8-2A16-4252-B0A9-377477947C6EQ47409821-C87B0480-E67B-4DFD-BE15-9FA61FB96155Q47548602-716FECC5-F51C-42EB-8BFD-2299A9FF7044Q48124218-73D5C766-5B1A-4EC4-8A47-0D2052F8EA31Q54084923-6A28C371-24CB-45F1-852C-1985BFEEAA7F
P2860
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Correlation between array-comp ...... prognostic factor in myeloma.
@ast
Correlation between array-comp ...... prognostic factor in myeloma.
@en
Correlation between array-comp ...... prognostic factor in myeloma.
@nl
type
label
Correlation between array-comp ...... prognostic factor in myeloma.
@ast
Correlation between array-comp ...... prognostic factor in myeloma.
@en
Correlation between array-comp ...... prognostic factor in myeloma.
@nl
prefLabel
Correlation between array-comp ...... prognostic factor in myeloma.
@ast
Correlation between array-comp ...... prognostic factor in myeloma.
@en
Correlation between array-comp ...... prognostic factor in myeloma.
@nl
P2093
P2860
P356
P1433
P1476
Correlation between array-comp ...... prognostic factor in myeloma.
@en
P2093
P L Bergsagel
S Van Wier
P2860
P2888
P304
P356
10.1038/LEU.2010.21
P577
2010-03-11T00:00:00Z
P5875
P6179
1040597154